Letter of support
•
1 like•1,821 views
he Food and Drug Administration (FDA) sent an open letter to the pharmaceutical industry to show their support for using biomarkers to better select clinical trial participants in the earliest stages of Alzheimer’s. - See more at: http://www.mycartis.net/blog/?p=130
